Clinical Trial Update: The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens [Phase 1]

View source ↗

Summary

Phase 1 study examining whether deferasirox alters response rate in patients with acute myeloid leukemia or acute lymphoblastic leukemia who have not received s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 1 | Status: UNKNOWN